GPhA tallies savings from generic drug use
The U.S. health care system saved a record $254 billion last year through the use of lower-cost generic drugs, the Generic Pharmaceutical Association (GPhA) reports.
Supplier News
Carmex teams up with Green Bay Packers
Carma Laboratories Inc. has unveiled a multi-year partnership between its Carmex lip care brand and the National Football League’s Green Bay Packers.
Mylan gains FTC clearance for Perrigo bid
Mylan N.V. has received clearance from the Federal Trade Commission for its proposal to acquire Perrigo Co. plc after agreeing to divest certain generic drug products. The regulatory approval leaves Mylan’s hostile bid in the hands of Perrigo shareholders, who have until Nov.
Coty reorganizes for addition of P&G beauty businesses
Coty Inc. has unveiled a new leadership and business structure that will go into effect after the closing of its deal to merge with a collection of Procter & Gamble Co. beauty care brands. Coty said Tuesday that its business will be organized into three units: the Coty Luxury Division, focused on
Skinfix debuts diabetic skin care line at Rite Aid
Skinfix Inc. has launched a natural, therapeutic body skin care line for diabetics at Rite Aid. Skinfix said Monday that the Skinfix Diabetic Relief Skincare Regimen includes Skinfix Moisturizing Body Wash, Skinfix Daily Relief Lotion, Skinfix Hand Relief Cream and Skinfix Healing Foot & Leg Balm.
Markwins creates CFO post
Leslie Hernandez has been promoted to chief financial officer at Markwins International. Markwins said Monday that as CFO, Hernandez assumes a newly created senior leadership role at the beauty care company, reporting directly to Eric Chen, chairman and chief executive officer.
USP rolls out GMP audit program for dietary supplements
The U.S. Pharmacopeial Convention (USP) is expanding its verification services to include a new Good Manufacturing Practice (GMP) audit program for dietary supplement and dietary ingredient manufacturers.
Mylan names GSK veteran as global OTC leader
Mylan N.V. has tabbed GlaxoSmithKline Consumer Healthcare veteran Ranjan Ray Chaudhuri to serve as global commercial lead of Mylan’s over-the-counter business. Chaudhuri will report to Rajiv Malik, president of Mylan.
Diva International sales exec promoted to VP
John Szustaczek has been promoted to vice president of sales and marketing, Diva International Inc., maker of The DivaCup. Diva said Monday that Szustaczek has played an integral role in the growth of the menstrual care product company since joining it in 2012 as director of sales and marketing.
Sanofi recalls all Auvi-Q epinephrine injectors
Sanofi US has voluntarily recalled all Auvi-Q epinephrine injectors, used for the emergency treatment of anaphylaxis, a serious allergic reaction. Sanofi said Friday that the recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.
TCGRx’s TheBox promotes medication adherence
TCGRx has introduced TheBox, a personal, timed drug dispensing unit designed to help patients adhere to their medication regimen.
Allergan, Pfizer: We’re in discussions
Allergan plc and Pfizer Inc. have confirmed they’re exploring a possible combination. Dublin, Ireland-based Allergan released a statement Thursday saying it’s in early talks with Pfizer about a possible deal, and Pfizer later affirmed Allergan’s statement.
FTC comments on FDA biosimilar naming guidance
The staff of the Federal Trade Commission has submitted comment for the Food and Drug Administration’s draft guidance on nonproprietary names for biological products.
Snyder’s-Lance to acquire Diamond Foods
Snyder’s-Lance Inc. plans to buy Diamond Foods Inc. in a cash and stock deal valued at about $1.91 billion. The companies said Wednesday that the agreement, which includes the assumption of about $640 million in debt, will create a complementary, diversified portfolio of branded snack products.
Aurobindo generic of Ultram ER OK’d by FDA
Aurobindo Pharma Ltd. has received final approval from the Food and Drug Administration for tramadol hydrochloride extended-release tablets, an opioid pain medication (Class IV), in dosages of 100 mg, 200 mg and 300 mg.
Endo cleared to market Belbuca dissolving film painkiller
Endo Pharmaceuticals Inc. and BioDelivery Sciences International Inc. have gained approval from the Food and Drug Administration for Belbuca buccal film (buprenorphine), an opioid treatment for chronic pain.